FluoroPharma Medical Secures $2,355,621 New Round

  • Feed Type
  • Date
    7/11/2011
  • Company Name
    FluoroPharma Medical
  • Mailing Address
    500 Boylston Street Boston, MA 02116
  • Company Description
    FluoroPharma, Inc., a privately-held molecular imaging company headquartered in Boston MA, engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD).
  • Website
    http://www.fluoropharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,355,621
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.